Treatments for uremic bleeding target the various factors that seem to have a role in platelet dysfunction. Interventions can exert acute (within 6 h) or delayed (within several weeks) effects, and ...

A trial supports the use of the calcineurin-inhibitor tacrolimus as a targeted treatment for uremic pruritus and introduces IL-13 inhibition as a viable mechanism to address cytokine-mediated itch.

Please provide your email address to receive an email when new articles are posted on . Researchers reviewed the efficacy of ravulizumab based on 2-year data from two phase 3, single-arm studies. eGFR ...

Please provide your email address to receive an email when new articles are posted on . Registry data showed efficacy of ravulizumab was similar to that of eculizumab. No unexpected adverse events ...

For years, dialysis has been the standard treatment for uremia. However, regular, long-lasting therapy sessions tethered to an essentially unmovable machine are not ideal for patients. After ...

A study links certain uremic toxins with cytokines and processes associated with red blood cell death in patients on dialysis. Specific uremic toxins may spur eryptosis and inflammation and contribute ...